A once-daily pill for ulcerative colitis has delivered strong results in a clinical trial, easing symptoms even in patients ...

Subcutaneous vedolizumab dose intensification restored steroid-free clinical response in approximately one-third of patients with IBD.

Experts discuss the central role of patient education and the strategic use of topical therapies in managing atopic dermatitis (AD), emphasizing the need for clear communication, age-appropriate ...